Document Detail


Docosahexaenoic Acid Supplementation Improved Lipocentric but Not Glucocentric Markers of Insulin Sensitivity in Hypertriglyceridemic Men.
MedLine Citation:
PMID:  21999398     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Background: Increase in obesity and metabolic syndrome are associated with increases in insulin resistance (IR) and type 2 diabetes mellitus. Results from animal intervention studies and human epidemiological studies suggest that n-3 polyunsaturated fatty acids can prevent and reverse IR, but results from human intervention studies have varied. Results from some human and animal studies suggest that docosahexaenoic acid (22:6n-3; DHA) may be more effective than eicosapentaenoic acid (20:5n-3; EPA) in the prevention of IR. Methods: By using a placebo-controlled, parallel study design, we examined the effects of DHA supplementation (3 grams/day, 90 days) in the absence of EPA on glucocentric and lipocentric markers of IR in hypertriglyceridemic men (n=14-17/group). Results: DHA supplementation increased fasting plasma glucose concentration by 4.7% (P<0.05), but did not alter other indices of IR based on fasting (insulin and homeostasis model assessment of insulin resistance [HOMA-IR]) or postprandial insulin and glucose concentrations (areas under curves for insulin and glucose, Matsuda index). Glucose increased by 2.7% in the placebo group and was not significant; increases in glucose in the two groups did not differ from each other. DHA decreased circulating concentrations of several lipocentric markers of IR, including plasma concentrations of nonesterified fatty acids (13.0%), small, dense low-density lipoprotein (LDL) particles (21.7%), and ratio of tryglycerides to high-density lipoprotein cholesterol (TG/HDL-C) (34.0%) (P<0.05). None of the variables changed in the placebo group. Conclusions: Our results suggest that lipocentric markers of IR are more responsive to DHA supplementation than the glucocentric markers. Future studies with DHA in prediabetic subjects and direct measures of insulin sensitivity are needed.
Authors:
Darshan S Kelley; Yuriko Adkins; Leslie R Woodhouse; Arthur Swislocki; Bruce E Mackey; David Siegel
Related Documents :
6292648 - Insulin prevention of impaired renal calcium transport in alloxan-diabetic rats.
16759828 - Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol die...
15648408 - Effect of extracts of murraya koenigii leaves on the levels of blood glucose and plasma...
9202658 - Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
3105988 - Plasma and testicular testosterone in experimental diabetic rats.
21533898 - Non-invasive investigation of kidney disease in type 1 diabetes by magnetic resonance i...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-14
Journal Detail:
Title:  Metabolic syndrome and related disorders     Volume:  -     ISSN:  1557-8518     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101150318     Medline TA:  Metab Syndr Relat Disord     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Western Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, and Department of Nutrition, University of California , Davis, California.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Gender-Stratified Comparative Analysis of Various Definitions of Metabolic Syndrome and Cardiovasc...
Next Document:  Radiofrequency Coagulation-Assisted Laparoscopic Partial Nephrectomy Without Hilar Clamping: A Feasi...